---
$id: https://graph.org.ai/products/commodity/51241253
$type: Product
source: UNSPSC
code: "51241253"
title: "Tioxolone"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tioxolone

**UNSPSC Code**: 51241253
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an astringent with the molecular formula C7H4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S0FAJ1R9CD, chemically known as 1,3-benzoxathiol-2-one, 6-hydroxy- but generally known as tioxolone, which bears US NIH Compound Identifier 72139. European Medicines Agency schedules Tioxolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11100MIG. The term TIOXOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules tioxolone in its Anatomical Therapeutic Chemical (ATC) Classification. TIOXOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tioxolone under HS 29349990 and SITC 51579. As of Q4 2014, TIOXOLONE remains the US FDA Preferred Term for this commodity. Tioxolone bears US NLM identifiers UMLS ID C2699951 and NCI Concept Code C76521. SMILES: S1C2C(OC1=O)CC(O)CC2.

